The size of the Latin American High-Resolution Melting Analysis Market is valued at USD 45.84 million in 2022. It is projected to be growing at a CAGR of 3.1% and worth USD 53.40 million by 2027.
The growing patient population, improved healthcare, and key players' presence are impelling the high-resolution melting analysis market in Latin America. Increasing per capita income and Y-O-Y growth in the incidence of genetic disorders and chronic diseases are further accelerating the market growth. Increasing extensive usage of technologies such as epigenetic and mutation scanning and growing investment from different sectors for the research and development activities is to surge the growth in demand for the high-resolution melting analysis market.
Lack of awareness and low perforation of high-resolution melting analysis hinders the market's growth rate in LATAM. Concerns associated with data storage and technical restriction regarding the high-resolution melting-QPCR analysis are restraining market growth. Differences in advanced technology also obstruct the development of HRM analysis.
This research report on Latin American High-Resolution Melting Analysis Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2025.
By Product And Service:
By End User:
An increase in infectious diseases and growing alertness of personalized medicine, and mounting public and private investments in the genomics sector are likely to propel the market growth. Countries like Brazil, Mexico, Argentina, Chile, and the Rest of Latin America are projected to showcase promising development in upcoming years. Availability of developed reimbursement replacements, technology advances, high awareness regarding different diagnostic tools available, and pertaining advantages impact the HRM analysis market positively during the assessment period.
Companies in the Latin American High-Resolution Melting Analysis market are Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). Other players in the market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com